Other Industry News

Lee's Pharm and SillaJen Approved for China Immunotherapy Trial

Lee's Pharm received CFDA approval for a Phase III trial of Pexa-Vec in patients with advanced liver cancer. The study is part of the PHOCUS global trial that was started in 2015. Lee's Pharm own... Full Story

Geneseeq Raises "Hundred of Millions of RMB" in C Round to Develop NGS

Geneseeq, a Nanjing-Toronto genetic sequencing company, closed a C funding round of "hundreds of millions of RMB," according to the company. Founded in 2008, Geneseeq focuses on genetic sequenc... Full Story

Cardinal Health Plans $1.5 Billion Sale of China Drug Distribution Business

Cardinal Health, the second largest drug distributor in the US, is reported to be actively seeking a buyer for its China drug operations, with bids expected between $1.2 billion and $1.5 billion, accordi... Full Story

Huayi Joins $17M Round In Chinese Surgical Navigation Device Firm Symbow Medical

Huayi Capital, a Chinese healthcare-focused investment fund, has led a RMB120 million (US$17 million) series A round in Symbow Medical, a Beijing-based surgical navigation device developer. National E... Full Story

iKang Forms $74 Million Partnership for New China Healthcare Clinics

iKang Healthcare will form an investment partnership with China Industrial Asset Management to build and/or buy more China clinics. iKang operates a chain of private preventive healthcare clinics in Chin... Full Story

Shanghai-Israel Fund Co-Leads $9 Million Funding of Rapid Medical

The Shanghai-Israel Investment Fund and BRM Group, an Israeli investment firm, co-led a $9 million Series B financing in Israel's Rapid Medical. Rapid is developing two neurovascular interventional d... Full Story

VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

, announced it will host a conference call tomorrow, July 20 at 8:30 AM U.S. Eastern Time to discuss its participation in a large multi-center clinical study with the Great Lakes New England C... Full Story

New industrial wave will boost economy

The nation's next wave of growth will be fueled by new industries such as biotechnology, clean energy and advanced manufacturing, according to a government think thank. The transformation is expected ... Full Story

Beijing eases oversight of some investments overseas

China will relax its supervision of outbound investment projects, with attention focusing only on investment in several key industries after tightened measures were implemented last year. "Regulatory... Full Story

C-Bridge Closes $400 Million China Healthcare Fund

C-Bridge Capital, a China private equity firm with a life science focus, closed its second fund, C-Bridge Healthcare Fund II, at its $400 million cap. C-Bridge is a subsidiary of New York's Island Ca... Full Story


Company Search

Upcoming Events More